In a strategic initiative to streamline operations, Pfizer said it would close facilities in Durham and Morrisville, North Carolina. The company aims to cut at least $3.5 billion in costs. The company now employs more than 80,000 people worldwide, with roughly 4,000 based in North Carolina. The closures will not affect Pfizer’s two largest facilities…
Why Wake County, North Carolina is gaining ground as a biotech hub
Wake County in North Carolina is actively working to recruit life sciences companies. Those efforts are proving successful. Amgen (Nasdaq:AMGN) recently broke ground on a $550 million biomanufacturing plant in Holly Springs, a town of about 41,000 in the county. The company anticipates that the facility will be operational in 2025. In October, Fujifilm Diosynth…
Lilly to invest $1B in new plant in North Carolina
Eli Lilly and Co. (NYSE:LLY) said it would invest more than $1 billion to build a new manufacturing facility in Concord, North Carolina. The company says it would hire almost 600 new employees to staff the new site, which will include a campus of five buildings focused on manufacturing parenteral (injectable) products and devices. The…